These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1757112)

  • 1. Enhancement of MHC class II antigen expression by exposure to Candida albicans.
    Ashman RB
    Immunol Lett; 1991 Oct; 30(2):255-60. PubMed ID: 1757112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen presentation by human monocytes: effects of modifying major histocompatibility complex class II antigen expression and interleukin 1 production by using recombinant interferons and corticosteroids.
    Rhodes J; Ivanyi J; Cozens P
    Eur J Immunol; 1986 Apr; 16(4):370-5. PubMed ID: 2422040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow colony-formation in vitro after infection of genetically defined inbred mice with Candida albicans.
    Wanasaengsakul S; Ashman RB
    Microb Pathog; 2004 Apr; 36(4):211-7. PubMed ID: 15001227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-33 Coordinates Innate Defense to Systemic
    Nguyen NZN; Tran VG; Baek J; Kim Y; Youn EH; Na SW; Park SJ; Seo SK; Kwon B
    J Immunol; 2022 Feb; 208(3):660-671. PubMed ID: 35022276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse candidiasis. II. Host responses are T-cell dependent and regulated by genes in the major histocompatibility complex.
    Ashman RB
    Immunogenetics; 1987; 25(3):200-3. PubMed ID: 2881888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection.
    Mazzaccaro RJ; Gedde M; Jensen ER; van Santen HM; Ploegh HL; Rock KL; Bloom BR
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11786-91. PubMed ID: 8876215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma.
    Chan JL; Tang KC; Patel AP; Bonilla LM; Pierobon N; Ponzio NM; Rameshwar P
    Blood; 2006 Jun; 107(12):4817-24. PubMed ID: 16493000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Instillation of allogeneic lung antigen-presenting cells deficient in expression of major histocompatibility complex class I or II antigens have differential effects on local cellular and humoral immunity and on pathology in recipient murine lungs.
    Heidler KM; Baker K; Woods K; Schnizlein-Bick C; Cummings OW; Sidner R; Foresman B; Wilkes DS
    Am J Respir Cell Mol Biol; 2000 Oct; 23(4):499-505. PubMed ID: 11017915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effector function of leucocytes from susceptible and resistant mice against distinct isolates of Candida albicans.
    Hu Y; Farah CS; Ashman RB
    Immunol Cell Biol; 2006 Oct; 84(5):455-60. PubMed ID: 16869942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presentation of exogenous antigens by macrophages: analysis of major histocompatibility complex class I and II presentation and regulation by cytokines.
    Kovacsovics-Bankowski M; Rock KL
    Eur J Immunol; 1994 Oct; 24(10):2421-8. PubMed ID: 7925570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelin ingestion alters macrophage antigen-presenting function in vitro and in vivo.
    van Zwam M; Samsom JN; Nieuwenhuis EE; Melief MJ; Wierenga-Wolf AF; Dijke IE; Talens S; van Meurs M; Voerman JS; Boven LA; Laman JD
    J Leukoc Biol; 2011 Jul; 90(1):123-32. PubMed ID: 21486907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MHC antigen induction by interferon gamma on cultured mouse pancreatic beta cells and macrophages. Genetic analysis of strain differences and discovery of an "occult" class I-like antigen in NOD/Lt mice.
    Leiter EH; Christianson GJ; Serreze DV; Ting AT; Worthen SM
    J Exp Med; 1989 Oct; 170(4):1243-62. PubMed ID: 2507727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
    Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presentation of exogenous antigen with class I major histocompatibility complex molecules.
    Rock KL; Gamble S; Rothstein L
    Science; 1990 Aug; 249(4971):918-21. PubMed ID: 2392683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excessive degradation of intracellular protein in macrophages prevents presentation in the context of major histocompatibility complex class II molecules.
    Brazil MI; Weiss S; Stockinger B
    Eur J Immunol; 1997 Jun; 27(6):1506-14. PubMed ID: 9209504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine candidiasis: cell-mediated immune responses correlate directly with susceptibility and resistance to infection.
    Ashman RB
    Immunol Cell Biol; 1990 Feb; 68 ( Pt 1)():15-20. PubMed ID: 2180815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of thymus-independent type 2 antigens on MHC class II-restricted antigen presentation: comparative analysis of carbohydrate structures and the antigen presenting cell.
    González-Fernández M; Carrasco-Marín E; Alvarez-Domínguez C; Outschoorn IM; Leyva-Cobián F
    Cell Immunol; 1997 Feb; 176(1):1-13. PubMed ID: 9070312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strain differences in the severity of lesions in murine systemic candidiasis correlate with the production of functional gamma interferon by Candida-activated lymphocytes in vitro.
    Ashman RB; Bolitho EM
    Lymphokine Cytokine Res; 1993 Dec; 12(6):471-6. PubMed ID: 8123764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic macrophages: antigen presentation by liposomes bearing class II major histocompatibility complex (MHC) and membrane interleukin-1 (IL-1).
    Bakouche O; Lachman LB
    J Clin Immunol; 1989 Sep; 9(5):369-77. PubMed ID: 2559926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.